Shiraz E-Medical Journal
Scopus by Title (Ref)
1. Comparison of three different therapies for cutaneous leishmaniasis and identification of the etiologic isolates in Isfahan, Iran
- Abdellahi L. , et al.
3. Allergic reactions to meglumine antimoniate while treating cutaneous leishmaniasis
- Brasileiro A. , et al.
4. Iranian native plants on treatment of cutaneous leishmaniosis: A narrative review
- Moghaddas E. , et al.
5. PCR-RFLP diagnosis and characterization of Leishmania species causing human cutaneous Leishmaniasis and evaluation of treatment times with glucantime in these patients
- Hashemi N. , et al.
6. The skin side effects of topical glucantime in patients with cutaneous leishmaniasis
- Nilforoushzadeh M.A. , et al.
7. Comparison between combination therapy of oral terbinafine and cryotherapy versus systemic meglumine antimoniate and cryother-apy in cutaneous leishmaniasis: A randomized clinical trial
- Farajzadeh S. , et al.
8. Therapeutic and adverse effects of standarddose and low-dose meglumine antimoniate during systemic treatment of Syrian cutaneous leishmaniasis patients
- Shanehsaz S. , et al.
9. Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis
- Esfandiarpour I. , et al.
10. Identification of leishmania species and treatment courses in patients with leishmaniasis in Isfahan, Iran
- Hejazi S.H. , et al.
11. Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis
- Pourmohammadi B. , et al.
12. Treatment approaches for cutaneous leishmaniasis
- Aytekin S. , et al.